Oncology: Oncology II: Common Cancer Types & Treatment Flashcards
Complete response is when
treatment has destroyed all known tumors
Partial response is when
at least 30% of tumor has been eliminated
BRCA1 and BRACA2 Gene mutations
normally genes suppress tumor growth
mutations prevent cell repair and inc breast cancer mutations
Klinefelter syndrome
Men with 1 Y, and multiple X
higher risk of breast cancer
Hormone-sensitive cancer treatment
treated with adjuvant (endocrine) therapy for 5-10yrs to suppress cancer recurrence
1st line adjuvant txm for premenopausal females with hormone-sensitive cancer
tamoxifen
SERM for breast cancer prevention in post menopausal females at risk for cancer?
Raloxifene
also inc bone density, indicated for osteoporosis prevention but not 1st line due to hot flashes/risk of blood clots
Why are Aromatase inhibitors not useful in premenopausal women
AIs reduce estrogen production by blocking aromatase enzyme, but dont block ovarian estradiol production
HER2 overexpression
oncogene that promotes breast tumor growth
20% of breast tumors over express HER2 on cell surface
SERMs Boxed warnings
inc risk of uterine or endometrial cancer
inc risk of thromboembolic events
QT prolongation
SERMs Contraindications
Dont use w/ warfarin = tamoxifen
Hx of DVT/PE = tamoxifen/raloxifene
pregnancy/breast feeding = raloxifene
QT prolongation = tamoxifen
SERMs side effects
Hot flashes
night sweats
vaginal bleeding/spotting
vaginal discharge/dryness/itchy
dec libido
weight gain
Dec bone density, supplement with calcium/vit D
Tamoxifen = teratogenic
Selective Estrogen Receptor Degrader (SERD)
Fulvestrant (Faslodex)
Fulvestrant (Faslodex) SE
SE: inc LFTS, hot flashes, injection site pain
Aromatase inhibitors
Anastrazole
Letrozole
Exemestane
Aromatase inhibitors info
Higher risk of osteoporosis
higher risk of CVS compared to SERMs
Aromatase inhibitors CI and SE
CI: pregnancy
SE: hot flashes/night sweats, arthralgia/myalgia
CDK4/6 inhibitors
Palbociclib
Abdemaciclib
Ribociclib
CDK4/6 inhibitors warnings & SE
Warnings: interstitial lung disease
SE: Neutropenia, anemia, nausea, diarrhea, fatigue, alopecia, blurred vision
Risk of TE events
Prostate Specific Antigen levels
> 4 = might be prostate cancer
4 - 10 = overlaps with BPH too
10 = prostate cancer likely
tumor flare in prostate cancer
When giving GnRH agonist, causes initial inc of T so its given with anti androgen, after awhile T drops and anti androgen can be stopped
due to negative feedback loop
GnRH agonists
Leuprolide (Lupin)
Goserelin (Zoladex)
Histrelin (Supprelin)
Triptorelin (Trelstar)
GnRH agonist Contraindications
Pregnancy
breastfeeding
GnRH agonist side effects
Hot flashes
impotence
gynecomastia
bone pain
QT prolongation
GnRH antagonist
Degarelix (Firmagon)
Relugolix (Orgovyx)
GnRH antagonist unique concerns
Osteoporosis. risk, consider vit D/calcium supp
No tumor flare, dont need anti androgen
GnRH antagonist CI and SE
CI: pregnancy
SE: similarly to GnRH agonist, Hot flashes, impotence, gyno, bone pain etc
1st gen anti androgen boxed warnings
Hepatotoxicity (Flutamide)
interstitial pneumonitis (nilutamide)
1st gen anti androgen meds
Bicalutamide
Flutamide
Nilutamide
1st gen anti androgen side effects
hot flashes
gyno
2nd gen anti androgen meds
Apalutamide (Erleada)
Darolutamide (Nubeqa)
Enzalutamide (Xtandi)
2nd gen Anti androgen warnings
seizures
myocardial ischemia
QT prolongation
can cause fetal harm
2nd gen Anti androgen side effects
HTN
peripheral edema
hot flashes
fatigue
Androgen Biosynthesis inhibitor
Abirateron (Zytiga)
Abirateron (Zytiga) side effects
mineralocorticoid excess
hepatotoxicity
Which patients body weight should be used for chemo dosing
their actual body weight
Cell cycle independent agents
Alkylating agents
platinum based compounds
Anthracyclines
Alkylating agents work by…..
cross-linking DNA strands and inhibiting protein synthesis and DNA synthesis
can cause DNA mutations and lead to secondary malignancies
Alkylating agents
Cyclophosphamide
Ifosfamide (Ifex)
Carmustine/Lomustine
Busulfan (Myleran)
Mitomycin
Cyclophosphamide and Ifosfamide unique concerns
Hemorrhagic cystitis = adequate hydration and use Mesna
Mesna given prophylactically with Ifosfamide and high dose cyclophosphamide
Alkylating agent boxed warnings
Myelosuppresion
Hemorrhagic cystitis
pulmonary toxicity = carmustine
neurotox = ifosfamide
hepatic necrosis = dacarbazine
Alkylating agents warnings
severe skin reactions, SJS/TEN
reactivation of infections = HBV, CMW, TB, HSV
hepatotoxicity
Alkylating agent side effects
Pulmonary toxicity = busulfan, carmustine/lomustine
Mod-high emetic potential
Mitomycin unique concerns
vesicant, antidote is DMSO and cool compresses
IV = hazy blue and make piss blue/green
Mitomycin Boxed warnings
bone marrow suppression
hemolytic uremia syndrome
Mitomycin CI
thrombocytopenia
coagulopathy
bleeding
Mitomycin SE
N/V
fatigue
alopecia
mucos membrane toxicity
leukopenia
Platinum based therapies
Cisplatin
Carboplatin
Oxaliplatin
Platinum based therapies common side effects
peripheral sensory neuropathy
ototoxicity
nephrotoxicity
Which platinum based therapy has highest risk of nephrotoxicity and CINV
Cisplatin
Cisplatin unique concerns
Nephro/Ototoxicity = cumulative
Amifostine = chemoprotectant used to prevent nephrotoxicity
highly emetic
Cisplatin boxed warnings
Anaphylactic like reactions, inc with repeated exposures, caution when > 6 cycles used
Cisplatin doses > 100mg/m2/cycle = check by provider
myelosuppresion
Oxaliplatin unique concerns
cold sensitivity = drinking cold beverages, eating ice cream etc
Platinum based therapies side effects
peripheral neuropathy
inc LFT
N/V
QT prolongation = oxaliplatin
Anthracyclines
Doxorubicin (Adriamycin)
Doxorubicin liposomal
Mitoxantrone
Doxorubicin unique concerns
potent vesicant
drug is red = discoloration of sweat, tears, urin
total lifetime dose not to exceed 450-550mg/m2
Dexrazoxane = for extravasation/chemoprotectant
Doxorubicin, other - ubicins boxed warnings
myocardial toxicity
vesicant
myelosuppresion
secondary malignancy
Doxorubicin, other -ubicins side effect
N/V - use antiemetics